We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Dr Eswara Reddy, Joint Drug Controller General of India has asked industry associations to make the representations on the amendments required in the recently released detailed production linked incentive (PLI) scheme.